168 related articles for article (PubMed ID: 16128567)
1. Characterization of Vibrio cholerae neuraminidase by a novel mechanism-based fluorescent labeling reagent.
Hinou H; Kurogochi M; Shimizu H; Nishimura S
Biochemistry; 2005 Sep; 44(35):11669-75. PubMed ID: 16128567
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based inhibitors to probe transitional states of glycoside hydrolases.
Hinou H; Kurogochi M; Nishimura S
Methods Enzymol; 2006; 415():202-12. PubMed ID: 17116476
[TBL] [Abstract][Full Text] [Related]
3. Sialic acid recognition by Vibrio cholerae neuraminidase.
Moustafa I; Connaris H; Taylor M; Zaitsev V; Wilson JC; Kiefel MJ; von Itzstein M; Taylor G
J Biol Chem; 2004 Sep; 279(39):40819-26. PubMed ID: 15226294
[TBL] [Abstract][Full Text] [Related]
4. A strategy for neuraminidase inhibitors using mechanism-based labeling information.
Hinou H; Miyoshi R; Takasu Y; Kai H; Kurogochi M; Arioka S; Gao XD; Miura N; Fujitani N; Omoto S; Yoshinaga T; Fujiwara T; Noshi T; Togame H; Takemoto H; Nishimura S
Chem Asian J; 2011 Apr; 6(4):1048-56. PubMed ID: 21305698
[TBL] [Abstract][Full Text] [Related]
5. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
Kai H; Hinou H; Nishimura S
Bioorg Med Chem; 2012 Apr; 20(8):2739-46. PubMed ID: 22410247
[TBL] [Abstract][Full Text] [Related]
6. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase.
Haselhorst T; Wilson JC; Thomson RJ; McAtamney S; Menting JG; Coppel RL; von Itzstein M
Proteins; 2004 Aug; 56(2):346-53. PubMed ID: 15211517
[TBL] [Abstract][Full Text] [Related]
7. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
[TBL] [Abstract][Full Text] [Related]
8. Macrocyclic mechanism-based inhibitor for neuraminidases.
Kai H; Hinou H; Naruchi K; Matsushita T; Nishimura S
Chemistry; 2013 Jan; 19(4):1364-72. PubMed ID: 23233350
[TBL] [Abstract][Full Text] [Related]
9. Anti-viral inhibitor binding to influenza neuraminidase by MALDI mass spectrometry.
Swaminathan K; Downard KM
Anal Chem; 2012 Apr; 84(8):3725-30. PubMed ID: 22409142
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of p-nitrophenyl 5-acetamido-3,5-dideoxy-alpha-D-glycero-D-galacto-2-nonulopyranosid onic acid, a chromogenic substrate for sialidases.
Eschenfelder V; Brossmer R
Carbohydr Res; 1987 May; 162(2):294-7. PubMed ID: 2885090
[No Abstract] [Full Text] [Related]
11. Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity.
Ohuchi M; Feldmann A; Ohuchi R; Klenk HD
Virology; 1995 Sep; 212(1):77-83. PubMed ID: 7676651
[TBL] [Abstract][Full Text] [Related]
12. 2,3-Didehydro-2-deoxysialic acids structurally varied at C-5 and their behaviour towards the sialidase from Vibrio cholerae.
Schreiner E; Zbiral E; Kleineidam RG; Schauer R
Carbohydr Res; 1991 Sep; 216():61-6. PubMed ID: 1797392
[TBL] [Abstract][Full Text] [Related]
13. One-bead-one-inhibitor-one-substrate screening of neuraminidase activity.
Ying L; Gervay-Hague J
Chembiochem; 2005 Oct; 6(10):1857-65. PubMed ID: 16149103
[TBL] [Abstract][Full Text] [Related]
14. Characterization of oligo- and polysialic acids by MALDI-TOF-MS.
Galuska SP; Geyer R; Mühlenhoff M; Geyer H
Anal Chem; 2007 Sep; 79(18):7161-9. PubMed ID: 17705556
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the polysialic acid-degrading endosialidase of bacteriophage K1F.
Stummeyer K; Dickmanns A; Mühlenhoff M; Gerardy-Schahn R; Ficner R
Nat Struct Mol Biol; 2005 Jan; 12(1):90-6. PubMed ID: 15608653
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent-assisted detection of oligosialyl units in glycoconjugates.
Sato C; Inoue S; Matsuda T; Kitajima K
Anal Biochem; 1999 Jan; 266(1):102-9. PubMed ID: 9887218
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain.
Crennell S; Garman E; Laver G; Vimr E; Taylor G
Structure; 1994 Jun; 2(6):535-44. PubMed ID: 7922030
[TBL] [Abstract][Full Text] [Related]
18. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor.
Varghese JN; McKimm-Breschkin JL; Caldwell JB; Kortt AA; Colman PM
Proteins; 1992 Nov; 14(3):327-32. PubMed ID: 1438172
[TBL] [Abstract][Full Text] [Related]
19. High Production of Neuraminidase by a Vibrio cholerae Non-O1 Strain--the First Possible Alternative to Toxigenic Producers.
Eneva RT; Engibarov SA; Petrova P; Abrashev R; Strateva T; Kolyovska V; Abrashev I
Appl Biochem Biotechnol; 2015 May; 176(2):412-27. PubMed ID: 25805019
[TBL] [Abstract][Full Text] [Related]
20. Site-specific fluorescent labeling of DNA using Staudinger ligation.
Wang CC; Seo TS; Li Z; Ruparel H; Ju J
Bioconjug Chem; 2003; 14(3):697-701. PubMed ID: 12757398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
